Stabilizing role of structural elements within the 5´ Untranslated Region (UTR) and gag sequences in Mason-Pfizer monkey virus (MPMV) genomic RNA packaging.
Mason-Pfizer monkey virus (MPMV)
RNA packaging
RNA secondary structure
Retroviruses
U5/Gag LRIs
gag
Journal
RNA biology
ISSN: 1555-8584
Titre abrégé: RNA Biol
Pays: United States
ID NLM: 101235328
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
pubmed:
19
2
2019
medline:
27
11
2019
entrez:
19
2
2019
Statut:
ppublish
Résumé
The Mason-Pfizer monkey virus (MPMV) genomic RNA (gRNA) packaging signal is a highly-structured element with several stem-loops held together by two phylogenetically conserved long-range interactions (LRIs) between U5 and gag complementary sequences. These LRIs play a critical role in maintaining the structure of the 5´ end of the MPMV gRNA. Thus, one could hypothesize that the overall RNA secondary structure of this region is further architecturally held together by three other stem loops (SL3, Gag SL1, and Gag SL2) comprising of sequences from the distal parts of the 5´untranslated region (5' UTR) to ~ 120 nucleotides into gag, excluding gag sequences involved in forming the U5-Gag LRIs. To provide functional evidence for the biological significance of these stem loops during gRNA encapsidation, these structural motifs were mutated and their effects on MPMV RNA packaging and propagation were tested in a single round trans-complementation assay. The mutant RNA structures were further studied by high throughput SHAPE (hSHAPE) assay. Our results reveal that sequences involved in forming these three stem loops do not play crucial roles at an individual level during MPMV gRNA packaging or propagation. Further structure-function analysis indicates that the U5-Gag LRIs have a more important architectural role in stabilizing the higher order structure of the 5´ UTR than the three stem loops which have a more secondary and perhaps indirect role in stabilizing the overall RNA secondary structure of the region. Our work provides a better understanding of the molecular interactions that take place during MPMV gRNA packaging.
Identifiants
pubmed: 30773097
doi: 10.1080/15476286.2019.1572424
pmc: PMC6546405
doi:
Substances chimiques
5' Untranslated Regions
0
Gene Products, gag
0
RNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
612-625Références
J Virol. 1999 May;73(5):4127-35
pubmed: 10196309
Adv Pharmacol. 2000;48:29-73
pubmed: 10987088
J Virol. 2001 Jun;75(11):5129-40
pubmed: 11333894
Virology. 2001 Sep 15;288(1):81-8
pubmed: 11543660
J Biol Chem. 2002 Feb 22;277(8):5995-6004
pubmed: 11744696
J Virol. 2002 Dec;76(23):12381-7
pubmed: 12414982
J Biol Chem. 2003 Mar 28;278(13):11601-11
pubmed: 12458192
J Gen Virol. 2003 Mar;84(Pt 3):621-7
pubmed: 12604814
Virology. 2003 Apr 25;309(1):166-78
pubmed: 12726736
Virus Res. 2003 Jun;93(2):199-209
pubmed: 12782368
Virology. 1992 Aug;189(2):786-91
pubmed: 1322603
Virus Res. 2004 Jan;99(1):35-46
pubmed: 14687944
Nat Rev Microbiol. 2004 Jun;2(6):461-72
pubmed: 15152202
Retrovirology. 2004 Aug 18;1:22
pubmed: 15317659
Virology. 2004 Sep 15;327(1):111-20
pubmed: 15327902
Nature. 2004 Sep 30;431(7008):586-90
pubmed: 15457265
J Am Chem Soc. 2005 Mar 30;127(12):4223-31
pubmed: 15783204
Biochemistry. 2005 Jun 28;44(25):9058-66
pubmed: 15966729
Nat Rev Microbiol. 2005 Aug;3(8):643-55
pubmed: 16064056
J Virol. 2005 Nov;79(21):13817-21
pubmed: 16227303
Microbes Infect. 2006 Mar;8(3):767-78
pubmed: 16513389
J Virol. 2006 May;80(10):4691-7
pubmed: 16641262
J Am Chem Soc. 2007 Apr 11;129(14):4144-5
pubmed: 17367143
J Virol. 2007 Jul;81(14):7742-8
pubmed: 17494072
Adv Pharmacol. 2007;55:1-32
pubmed: 17586311
RNA. 2008 Dec;14(12):2597-608
pubmed: 18974279
Nat Protoc. 2009;4(10):1413-21
pubmed: 19745823
BMC Bioinformatics. 2010 Mar 15;11:129
pubmed: 20230624
J Mol Biol. 2010 Sep 3;401(5):996-1014
pubmed: 20600114
J Mol Biol. 2010 Oct 15;403(1):103-119
pubmed: 20732330
PLoS Pathog. 2010 Oct 07;6(10):e1001007
pubmed: 20949075
Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19248-53
pubmed: 20974908
Nucleic Acids Res. 2011 Aug;39(15):6692-704
pubmed: 21546549
Science. 2011 Oct 14;334(6053):242-5
pubmed: 21998393
Retrovirology. 2012 Jul 24;9:59
pubmed: 22828074
PLoS One. 2012;7(10):e47088
pubmed: 23077548
RNA. 2013 Jan;19(1):63-73
pubmed: 23188808
RNA. 2013 Dec;19(12):1648-58
pubmed: 24152551
Cell. 1986 May 9;45(3):375-85
pubmed: 2421920
Retrovirology. 2014 Nov 14;11:96
pubmed: 25394412
RNA. 2016 Jun;22(6):905-19
pubmed: 27095024
Viruses. 2016 Sep 10;8(9):
pubmed: 27626439
Viruses. 2016 Sep 12;8(9):
pubmed: 27626441
Viruses. 2016 Sep 20;8(9):null
pubmed: 27657110
Viruses. 2016 Oct 11;8(10):
pubmed: 27727192
RNA Biol. 2017 Jan 2;14(1):90-103
pubmed: 27841704
J Mol Biol. 2017 Aug 4;429(16):2542-2555
pubmed: 28673553
Front Microbiol. 2018 Mar 22;9:527
pubmed: 29623074
RNA Biol. 2018;15(8):1047-1059
pubmed: 29929424
Sci Rep. 2018 Aug 7;8(1):11793
pubmed: 30087395
J Natl Cancer Inst. 1986 Oct;77(4):957-65
pubmed: 3020302
J Virol. 1985 May;54(2):552-60
pubmed: 3989913
Science. 1984 Feb 10;223(4636):602-5
pubmed: 6695172
Science. 1984 Mar 9;223(4640):1083-6
pubmed: 6695196
J Virol. 1995 Jun;69(6):3282-9
pubmed: 7745675
J Virol. 1995 Apr;69(4):2175-86
pubmed: 7884866
J Natl Cancer Inst. 1975 Mar;54(3):651-8
pubmed: 804565
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1256-60
pubmed: 8108397
J Mol Biol. 1993 Jan 20;229(2):382-97
pubmed: 8429553
J Virol. 1993 May;67(5):2681-8
pubmed: 8474168
Science. 1996 Apr 12;272(5259):263-7
pubmed: 8602510
Virology. 1996 Aug 15;222(2):457-63
pubmed: 8806531
Virology. 1996 Oct 15;224(2):517-32
pubmed: 8874512
J Virol. 1997 Jun;71(6):4544-54
pubmed: 9151848
Virology. 1997 Sep 15;236(1):118-29
pubmed: 9299624
Nat Med. 1998 Mar;4(3):354-7
pubmed: 9500613
J Virol. 1998 Apr;72(4):3196-204
pubmed: 9525645
J Virol. 1998 Nov;72(11):9217-23
pubmed: 9765469